AddThis Feed Button "Frequently Copied, Never Duplicated"

Tuesday, November 28, 2006


For years we have warned against the over use of antibiotics, especially those containing aspartame (children's amoxicillin for example) and fluoride. Other concerns we have raised is the over use of SSRI anti-depressants and their association with the development of diabetes.

I guess we are not far removed from medical experimentation akin to that used at Tuskeegee Institute or in the Nazi regime.

Dr. Lisa Landymore-Lim, a PhD chemist specialising in immuniology, believes that a cause of insulin dependent childhood diabetes may be certain prescribed medical drugs. She's author of "Poisonous Prescriptions" in 1994. She was at first banned from entering Australia because of her research.
Two of the best known chemicals capable of damaging pancreatic beta cells - which produce insulin - are the antibiotics streptozocin & allaxan.
She was the first to notice that mothers who were prescribed more than 3 antibiotics during pregnancy were more likely to have asthmatic children. The Wellington Asthma
Research Group over a decade later finally reported that the earlier a child is exposed to antibiotics the more likely he is to develop asthma.
Some medical drugs displace zinc in the pancreas & attack the insulin-making cells. Such changes might activate the body's immune-defence system, resulting in antibodies directed against the beneficial beta cells, seeing them as a foreign body. She noticed big differences in diabetes rates in different UK areas & looked into doctors prescribing practices. East Anglia with the highest diabetes also has the highest
antibiotic prescribing rate compared with North West Thames area with the lowest diabetes & the lowest prescribing rate. Fourteen regions are listed in descending
order in the article.
Among the drugs suspected of being linked to diabetes are antibiotics such as amoxycillin & erythromycin; tranquillizers such as benzodiazopines & some blood pressure-lowering pills containing nifedipine.

No comments: